A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers

NCT00516945 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

110

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hepatitis B
Neoplasms

Interventions

DRUG: Lamivudine

Sponsor

Hospital Authority, Hong Kong